These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3933494)

  • 1. Dipeptide glycols: a new class of renin inhibitors.
    Hanson GJ; Baran JS; Lindberg T; Walsh GM; Papaioannou SE; Babler M; Bittner SE; Yang PC; Dal Corobbo M
    Biochem Biophys Res Commun; 1985 Oct; 132(1):155-61. PubMed ID: 3933494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New class of inhibitors specific for human renin.
    Papaioannou S; Hansen D; Babler M; Yang PC; Bittner S; Miller A; Clare M
    Clin Exp Hypertens A; 1985; 7(9):1243-57. PubMed ID: 3000656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new class of orally active glycol renin inhibitors containing phenyllactic acid at P3.
    Hanson GJ; Baran JS; Lowrie HS; Russell MA; Sarussi SJ; Williams K; Babler M; Bittner SE; Papaioannou SE; Yang PC
    Biochem Biophys Res Commun; 1989 Apr; 160(1):1-5. PubMed ID: 2496685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced potency dipeptide glycol renin inhibitors: studies in vitro and in the conscious rhesus.
    Hanson GJ; Baran JS; Lowrie HS; Sarussi SJ; Yang PC; Babler M; Bittner SE; Papaioannou SE; Walsh GM
    Biochem Biophys Res Commun; 1987 Aug; 146(3):959-63. PubMed ID: 3304296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statine-containing dipeptide and tripeptide inhibitors of human renin.
    Kokubu T; Hiwada K; Nagae A; Murakami E; Morisawa Y; Yabe Y; Koike H; Iijima Y
    Hypertension; 1986 Jun; 8(6 Pt 2):II1-5. PubMed ID: 3087874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of analogues of the carboxyl protease inhibitor pepstatin. Effects of structure on inhibition of pepsin and renin.
    Rich DH; Sun ET; Ulm E
    J Med Chem; 1980 Jan; 23(1):27-33. PubMed ID: 6767029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro and in vivo inhibition of renin by a thiazolylalanyl cyclostatine derivative].
    Muneta S
    Nihon Jinzo Gakkai Shi; 1989 Aug; 31(8):865. PubMed ID: 2512401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly potent and specific inhibitors of human renin.
    Kokubu T; Hiwada K; Sato Y; Iwata T; Imamura Y; Matsueda R; Yabe Y; Kogen H; Yamazaki M; Iijima Y
    Biochem Biophys Res Commun; 1984 Feb; 118(3):929-33. PubMed ID: 6422931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orally potent human renin inhibitors derived from angiotensinogen transition state: design, synthesis, and mode of interaction.
    Iizuka K; Kamijo T; Harada H; Akahane K; Kubota T; Umeyama H; Ishida T; Kiso Y
    J Med Chem; 1990 Oct; 33(10):2707-14. PubMed ID: 2120440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological activity of some transition-state inhibitors of human renin.
    Bühlmayer P; Caselli A; Fuhrer W; Göschke R; Rasetti V; Rüeger H; Stanton JL; Criscione L; Wood JM
    J Med Chem; 1988 Sep; 31(9):1839-46. PubMed ID: 3137345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic and enzyme inhibition studies of pepstatin analogues containing hydroxyethylene and ketomethylene dipeptide isosteres.
    Holladay MW; Salituro FG; Rich DH
    J Med Chem; 1987 Feb; 30(2):374-83. PubMed ID: 3100803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New renin inhibitors containing pseudodipeptidic units in P3-P2 and P1-P1' positions.
    Paruszewski R; Jaworski P; Bodnar M; Dudkiewicz-Wilczyńska J; Roman I
    Chem Pharm Bull (Tokyo); 2005 Oct; 53(10):1305-9. PubMed ID: 16204988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel nonpeptidic, orally active renin inhibitor.
    Morishima H; Koike Y; Nakano M; Atsuumi S; Tanaka S; Funabashi H; Hashimoto J; Sawasaki Y; Mino N; Nakano M
    Biochem Biophys Res Commun; 1989 Mar; 159(3):999-1005. PubMed ID: 2495004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human renin inhibiting dipeptide.
    Toda N; Miyazaki M; Etoh Y; Kubota T; Iizuka K
    Eur J Pharmacol; 1986 Oct; 129(3):393-6. PubMed ID: 3536533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin inhibitors containing conformationally restricted P1-P1' dipeptide mimetics.
    Williams PD; Perlow DS; Payne LS; Holloway MK; Siegl PK; Schorn TW; Lynch RJ; Doyle JJ; Strouse JF; Vlasuk GP
    J Med Chem; 1991 Mar; 34(3):887-900. PubMed ID: 2002469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An orally active renin inhibitor: cyclohexylnorstatine-containing dipeptide (KRI-1314).
    Miyazaki M; Etoh Y; Iizuka K; Toda N
    J Hypertens Suppl; 1989 Apr; 7(2):S25-7. PubMed ID: 2666609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization and in vivo evaluations of a series of small, potent, and specific renin inhibitors containing a novel Leu-Val replacement.
    Dellaria JF; Maki RG; Bopp BA; Cohen J; Kleinert HD; Luly JR; Merits I; Plattner JJ; Stein HH
    J Med Chem; 1987 Nov; 30(11):2137-44. PubMed ID: 3118024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A highly potent and long-acting oral inhibitor of human renin.
    Hiwada K; Kokubu T; Murakami E; Muneta S; Morisawa Y; Yabe Y; Koike H; Iijima Y
    Hypertension; 1988 Jun; 11(6 Pt 2):708-12. PubMed ID: 3134306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly potent and specific inhibitors of human renin.
    Kokubu T; Hiwada K; Murakami E; Imamura Y; Matsueda R; Yabe Y; Koike H; Iijima Y
    Hypertension; 1985; 7(3 Pt 2):I8-11. PubMed ID: 2987128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pepstatin analogues as novel renin inhibitors.
    Guégan R; Diaz J; Cazaubon C; Beaumont M; Carlet C; Clément J; Demarne H; Mellet M; Richaud JP; Segondy D
    J Med Chem; 1986 Jul; 29(7):1152-9. PubMed ID: 3543358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.